Revolution Medicines, Inc. is 1.7x more valuable than Moderna, Inc. by market capitalization ($30.65 B vs $18.25 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RVMD | MRNA |
|---|---|---|
| Market cap | $30.65 B | $18.25 B |
| US-listed rank | #454 | #650 |
| Revenue (latest FY) | $0.00 | $1.94B |
| Net income (latest FY) | -$1.13B | -$2.82B |
| Net margin | - | -145.2% |
| SEC filings | 782 | 1,447 |
Revolution Medicines, Inc. is 1.7x more valuable than Moderna, Inc. by market capitalization ($30.65 B vs $18.25 B).
In their latest fiscal years, Revolution Medicines, Inc. reported $0.00 in revenue while Moderna, Inc. reported $1.94B.
Full pages: Revolution Medicines, Inc. and Moderna, Inc., or browse the full rankings.